Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

332
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
332
Depression: Overview01:18

Depression: Overview

556
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
556
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

576
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
576
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

270
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
270
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

969
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
969

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EEG Signatures of Melancholia: An Update.

NeuroSci·2026
Same author

A systematic narrative review of the form, process, and function of sensory hyposensitivity in depression.

Translational psychiatry·2026
Same author

Camouflaging and autism: Conceptualisation and methodological issues.

Autism : the international journal of research and practice·2026
Same author

An exploration of the association between sub bands of gamma and individual symptoms of melancholia.

Behavioural brain research·2026
Same author

Resting-State EEG Correlates of Childhood Maltreatment and Depression: Potential Neurophysiological Links and Future Research Directions.

NeuroSci·2026
Same author

Associations Between Communication Skills and Social Anxiety in Children and Adolescents With Autism Spectrum Disorder: A Systematic Review.

Journal of speech, language, and hearing research : JSLHR·2025
Same journal

A review of Alzheimer's disease diagnosis and prognosis models based on multimodal deep learning.

Reviews in the neurosciences·2026
Same journal

<i>Helicobacter pylori</i> infection and neurological disorders: association, mechanisms, and clinical implications.

Reviews in the neurosciences·2026
Same journal

Role of Toll-like receptors and oral-gut-brain axis in neurodegenerative and neuropsychiatric disorders.

Reviews in the neurosciences·2026
Same journal

The potential mechanisms of exercise-regulated mechanically sensitive ion channels in promoting spinal cord injury repair: a hypothesis-driven narrative review.

Reviews in the neurosciences·2026
Same journal

Behavioral, neural and neurochemical basis of effort-related decision making.

Reviews in the neurosciences·2026
Same journal

Growth differentiation factor 11 (GDF11) signaling in neural stem cell regulation: molecular and cellular insights.

Reviews in the neurosciences·2026
See all related articles

Related Experiment Video

Updated: Nov 17, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

359

Default mode network activity in depression subtypes.

Bernard J Borserio1, Christopher F Sharpley1,2, Vicki Bitsika1

  • 1Brain-Behaviour Research Group, University of New England, Armidale, NSW, Australia.

Reviews in the Neurosciences
|February 14, 2021
PubMed
Summary
This summary is machine-generated.

This review explores the default mode network's (DMN) connection to four depression subtypes. Findings suggest targeting DMN activation may improve depression treatment outcomes.

Keywords:
DMNdepressiondiagnosis

More Related Videos

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

15.5K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.9K

Related Experiment Videos

Last Updated: Nov 17, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

359
Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

15.5K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Depression presents a significant global health challenge.
  • Traditional treatments for depression have limitations.
  • Emerging research focuses on neurobiology and personalized depression profiles.

Purpose of the Study:

  • To review the association between the default mode network (DMN) and four proposed depression subtypes.
  • To synthesize findings from the last 20 years of research on this topic.
  • To identify potential therapeutic implications of DMN research in depression.

Main Methods:

  • Literature search of studies from the past 20 years.
  • Identification and analysis of 62 relevant research papers.
  • Synthesis of findings on DMN aspects and depression subtypes.

Main Results:

  • The default mode network (DMN) shows associations with various aspects of the four depression subtypes.
  • Specific DMN activation and connectivity patterns are linked to different depression profiles.
  • Evidence suggests a role for the DMN in the neurobiological pathways of depression.

Conclusions:

  • Focusing on DMN activation and connectivity holds promise for novel depression therapies.
  • Potential therapeutic strategies include psychological therapies, transcranial magnetic stimulation, and new pharmacological models.
  • Understanding the DMN-depression subtype link may lead to individualized treatment approaches.